This site is intended for healthcare professionals
News

RAUORA phase III trial of cytisinicline shows non-inferiority to Chantix in smoking cessation.- Achieve Life Sciences

Read time: 1 mins
Last updated:30th Jun 2020
Published:30th Jun 2020
Condition: Smoking Cessation
Type: drug
Register free for full access to medthority.com